Man develops severe liver damage after taking epsom salts
A 38-year-old man developed serious liver damage after taking epsom salts to treat gallstones, reveal doctors in the journal BMJ Case Reports.
Oct 2, 2017
0
0
A 38-year-old man developed serious liver damage after taking epsom salts to treat gallstones, reveal doctors in the journal BMJ Case Reports.
Oct 2, 2017
0
0
(HealthDay)—Pioglitazone may not be effective for lowering blood glucose levels, although it is associated with slight improvement in liver function, in lipoatrophic diabetes induced by juvenile dermatomyositis, according ...
Sep 20, 2017
0
0
New research published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), suggests that an investigational neurological treatment derived from cannabis may alter the blood levels of commonly used ...
Aug 7, 2017
0
11
People taking a common rheumatoid arthritis medicine are not at increased risk of liver damage if they stick to 14 units of alcohol a week or fewer, a new study from The University of Manchester has found.
Mar 27, 2017
0
11
A team of Michigan State University researchers, led by James Luyendyk in the College of Veterinary Medicine, has uncovered a new pathway in the body that stimulates liver repair.
Jan 18, 2017
0
0
On March 29, Nature Genetics published a research article titled "Genetic lineage tracing identifies endocardial origin of liver vasculature," from Prof. ZHOU Bin's lab at the Institute for Nutritional Sciences (INS), Shanghai ...
Apr 6, 2016
0
5
A large multi-center clinical trial has found that a combination of antiviral medications can eradicate hepatitis C infection in more than 90 percent of patients with advanced liver disease. Known as the ASTRAL-4 trial, the ...
Nov 30, 2015
0
7
Liver transplantation is currently the only established treatment for patients with end stage liver failure. However, this treatment is limited by the shortage of donors and the conditional integrity and suitability of the ...
Aug 26, 2015
0
37
(HealthDay)—Technivie (ombitasvir, paritaprevir and ritonavir) has been approved by the U.S. Food and Drug Administration, in tandem with ribavirin, to treat hepatitis C genotype 4 infection among people without poor liver ...
Jul 25, 2015
0
13
When diabetes strikes, the brain is not the first thing that comes to mind.
Apr 7, 2015
0
234